Don Webber brings more than 25 years of medical device management expertiseContinue reading
Author Archive: AZBio
FDA Approves Genentech’s Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Invasive Disease After Neoadjuvant Treatment
– Approval based on data showing Kadcyla cut the risk of disease recurring by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer –
– Application approved under FDA’s Real-Time Oncology Review pilot program –
TGen plays key role in identifying foothold for leveraging cancer cell weakness
Nationwide effort reveals potential treatment option for pancreatic cancerContinue reading
Life’s many histories open new approaches to cancer
For most humans, a family of ten would be considered abundant. But for many other forms of life on earth, that’s.. well…chicken feed.Continue reading
New Radiosurgery Technique a Boon for Cancer Patients
Vastly shortens treatments for metastatic brain lesions
UA physicians and scientists developing technology to prevent adverse reactions to medications
The University of Arizona College of Medicine – Phoenix and Banner Health are collaborating to prevent life-threatening adverse reactions to medications with support from the Flinn Foundation.Continue reading
New, Minimally Invasive Treatment for Enlarged Prostate Shows Promise
TUCSON, Ariz. (Feb. 25, 2019) – University of Arizona interventional radiologists and urologists at Banner – University Medical Center Tucson have been working to improve the quality of life in men with benign prostatic hyperplasia (BPH).Continue reading